MENU
Nobio Ltd., developer of embedded, long-acting antimicrobial particle technology, today announced the closing of a $3.6 million investment by aMoon Fund and Dr. Ole Jensen. The proprietary, non-soluble Nobio particles feature high anti-microbial activity that does not involve chemical interaction…
We use cookies to make your website experience better. By accepting this notice and continuing to browse our website you confirm you accept our Terms of Use & Privacy Policy.
read more >>
View Print Edition
View Digital Edition
View Special Edition